Geode Capital Management
NVNO

Geode Capital Management’s enVVeno Medical NVNO Stock Holding History

Geode Capital Management’s Portfolio NVNO Stock Details NVNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-10,455
Closed -$106K – 4535
2026
Q1 		$106K Buy
10,455
+4,705
+82% +$51.5K ﹤0.01% 4121
2025
Q4 		$64.6K Hold
5,750
– – ﹤0.01% 4190
2025
Q3 		$182K Buy
5,750
+50
+0.9% +$5.11K ﹤0.01% 3954
2025
Q2 		$796K Buy
5,700
+63
+1% +$7.45K ﹤0.01% 3403
2025
Q1 		$519K Buy
5,637
+445
+9% +$49.6K ﹤0.01% 3530
2024
Q4 		$549K Buy
5,192
+887
+21% +$99.1K ﹤0.01% 3570
2024
Q3 		$506K Buy
4,305
+311
+8% +$57.1K ﹤0.01% 3575
2024
Q2 		$734K Buy
3,994
+67
+2% +$11.7K ﹤0.01% 3420
2024
Q1 		$748K Buy
3,927
+438
+13% +$78.6K ﹤0.01% 3467
2023
Q4 		$628K Buy
3,489
+840
+32% +$134K ﹤0.01% 3529
2023
Q3 		$500K Buy
2,649
+275
+12% +$45.9K ﹤0.01% 3603
2023
Q2 		$256K Hold
2,374
– – ﹤0.01% 3931
2023
Q1 		$393K Hold
2,374
– – ﹤0.01% 3739
2022
Q4 		$423K Buy
2,374
+26
+1% +$5.28K ﹤0.01% 3737
2022
Q3 		$516K Buy
2,348
+13
+0.6% +$2.77K ﹤0.01% 3705
2022
Q2 		$308K Buy
2,335
+48
+2% +$7.45K ﹤0.01% 4020
2022
Q1 		$509K Hold
2,287
– – ﹤0.01% 3923
2021
Q4 		$527K Buy
+2,287
New +$644K ﹤0.01% 4016
2021
Q3 		– Sell
-1,822
Closed -$437K – 4869
2021
Q2 		$437K Buy
1,822
+786
+76% +$169K ﹤0.01% 4004
2021
Q1 		$241K Buy
+1,036
New +$288K ﹤0.01% 4057

Other funds holding NVNO

KCM
Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Geode Capital Management's NVNO Position: Q2 2026 in Review

Geode Capital Management sold out of enVVeno Medical (NVNO) in Q2 2026, closing a stake of 10,455 shares — an estimated $106K sold.

Geode Capital Management first reported a position in NVNO in Q1 2021 and held it in 20 quarters. The position peaked at $796K in Q2 2025. 17 funds tracked by Wall St. Rank hold NVNO as of Q2 2026.

  • Geode Capital Management reported no remaining enVVeno Medical position as of Q2 2026 after selling out during the quarter.
  • Geode Capital Management sold 10,455 enVVeno Medical shares in Q2 2026, an estimated $106K.
  • Geode Capital Management first reported a position in enVVeno Medical in Q1 2021 and held it in 20 quarters.
  • Geode Capital Management's enVVeno Medical position peaked at $796K in Q2 2025.
  • 17 funds tracked by Wall St. Rank held enVVeno Medical as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.